Evidence map›Paper›PMID 40248090›Full record

ArticleFrontiers in pharmacology2025

Anticoagulation quality with warfarin therapy, and associated factors among adult outpatients at public hospitals in nekemte town, western Ethiopia: a retrospective study.

Firafan Shuma Teka, Ayana Tadesse Korsa, Habte Gebeyehu Bayisa, Dechasa Befikadu W/Senbat, Refisa Shifera Beyene, Dinka Dugassa Iticha, Birbirsa Sefera Senbeta

Abstract read
In one paragraph

Article in Frontiers in pharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Firafan Shuma TekaDepartment of Clinical Pharmacy and Pharmacy Practice, Institute of Health Sciences, Dambi Dollo University, Oromia, Ethiopia.
Ayana Tadesse KorsaDepartment of Clinical Pharmacy, Institute of Health Sciences, Wallaga University, Oromia, Ethiopia.
Habte Gebeyehu BayisaDepartment of Clinical Pharmacy, Institute of Health Sciences, Wallaga University, Oromia, Ethiopia.
Dechasa Befikadu W/SenbatDepartment of Medical Microbiology, Institute of Health Sciences, Dambi Dollo University, Oromia, Ethiopia.
Refisa Shifera BeyeneDepartment of Clinical Pharmacy, Institute of Health Sciences, Wallaga University, Oromia, Ethiopia.
Dinka Dugassa ItichaDepartment of Clinical Pharmacy, Institute of Health Sciences, Wallaga University, Oromia, Ethiopia.
Birbirsa Sefera SenbetaDepartment of Pharmacy, College of Health Science, Mettu University, Oromia, Ethiopia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The global prevalence of poor anticoagulation control with warfarin therapy is high. Similarly, the quality of anticoagulation control with warfarin therapy in Ethiopia has been reported to be poor, with a notable paucity of data, especially in the western part of the country. Objectives: This study aimed to evaluate the anticoagulation quality, and associated factors among adult outpatients on warfarin therapy at Wallaga University Referral Hospital and Nekemte Comprehensive Specialized Hospital, Nekemte town, Western Ethiopia. Methods: A retrospective study was conducted at public hospitals in Nekemte town from June 1 to 31 July 2023. Data were collected by reviewing patients' medical charts using a systematic random sampling technique. Time in the therapeutic range was determined using the Rosendaal method. The collected data were entered into EpiData version 4.6.0 and then exported to SPSS version 27.0 for analysis. Bivariable and multivariable logistic regression analyses were performed to identify significant associations. In the multivariable analysis, statistical significance was declared at a p-value of less than 0.05. Results: A total of 402 patient medical charts with warfarin indications were reviewed. The mean age of the study participants was 38.9 ± 17.9 years, and 271 (67.4%) were female. Good warfarin anticoagulation quality was observed in 36 (9%) of the patients. Aspirin use (AOR = 2.685; CI: 0.872-10.277; p-value = 0.002) and congestive heart failure (AOR = 4.392; CI: 1.028-18.768; p-value = 0.046) were identified as independent predictors of poor anticoagulation quality. Conclusion: Aspirin use and congestive heart failure were independent predictors of poor anticoagulation quality with warfarin therapy.

Indexed as

anticoagulation qualityassociated factorsnekemte townpublic hospitalswarfarin

Identifiers

PMID40248090
PMCPMC12003960

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.